Adjuvant treatment of breast cancer: sequence and duration of hormonal therapy.
نویسنده
چکیده
The role of hormones in the treatment of breast cancer has been recognized for more than a century, since Beatson published his observations on the effect of oophorectomy in patients with metastatic breast cancer in 1896 [1]. In the adjuvant setting the role of hormonal responsiveness and of hormonal treatments has been re-emphasized during the last Consensus Conference held in St. Gallen, Switzerland (Table 1) in 2005 [2]. However, important questions regarding selection of the hormonal manipulation, duration of the hormonal treatment and the best sequence of different hormones are still open and will be discussed.
منابع مشابه
مقایسه اثرات تاموکسیفن در بروز سنگهای صفراوی در بیماران زن مبتلا به کانسر پستان
Background & Aims: Tamoxifen is used in breast cancer as adjuvant hormonal therapy. Some studies have found effect of tamoxifen on bile components and gallstone formation. The purpose of the study was to find out the association between tamoxifen use in patient with breast cancer and gallstone formation. Materials & Methods: 780 patient with breast cancer who had undergone surgery in 3 hospita...
متن کاملRacial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
BACKGROUND Five-year breast cancer survival rates are lower among Hispanic and African-American women than among Non-Hispanic White women. Differences in breast cancer treatment likely play a role. Adjuvant hormonal therapies increase overall survival among women with hormone receptor-positive breast cancer. METHODS We examined racial/ethnic differences in use and duration of adjuvant hormona...
متن کاملEffect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer.
BACKGROUND On the basis of the lack of response of invasive lobular breast cancer to neoadjuvant chemotherapy, we questioned the effectiveness of adjuvant chemotherapy in relation to histology. PATIENTS AND METHODS Women with primary nonmetastatic invasive ductal or (mixed type) lobular breast cancer, aged 50-70 years, diagnosed between 1995 and 2008, were selected from the Netherlands Cancer...
متن کاملEffects of Melatonin on IL-6 Serum Level Changes and Fatigue Caused by Adjuvant Chemoradiotherapy in Breast Cancer Women: A Randomized Controlled Trial
Introduction: Cancer-related fatigue is one of the most common and debilitating complications of breast cancer. Cancer patients have been found to have lower levels of melatonin, and fatigue has been shown to be correlated with both melatonin and interleukin (IL-6) in cancer patients. This study aimed to evaluate the fatigue and serum level of IL-6 in response to melatonin treatment in breast c...
متن کاملNew Hormonal Therapies for Breast Cancer.
BACKGROUND: There has been an explosion in the development of hormonal therapies for the treatment of breast cancer. Several new agents have been approved for the treatment of breast cancer in the metastatic setting, and trials are ongoing in the adjuvant and prevention setting to improve hormonal therapy for the prevention and treatment of breast cancer. METHODS: The literature on new hormonal...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Annals of oncology : official journal of the European Society for Medical Oncology
دوره 17 Suppl 10 شماره
صفحات -
تاریخ انتشار 2006